Dr. Gerald Diaz @GeraldMD
48.6M 14.2K 7.5K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
13 results
pharmacology management dosing inhibitors agonists algorithm dpp4 glp1 renal acute aki antidiabetic causes ckd comparison decisionaid diabetic diagnosis differential gfr
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #medications #table ... comparison #management #endocrinology ... #dm2
Diabetes Medication Prescribing Algorithm - Dr. Eric Strong @DrEricStrong - Strong Medicine https://www.youtube.com/c/EricsMedicalLectures/featured #Diabetes #Medications #Prescribing #Algorithm #management
Diabetes Medication ... EricsMedicalLectures/featured #Diabetes ... #Medications #Prescribing ... Algorithm #management #endocrinology ... #dm2
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents #Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... Impairment #CKD #Table
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
- Pharmacology Summary ... Toxicities: Weight gain ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... Toxicities: • Joint pains ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... #Pharmacology #Medications ... #DM2 #Diabetes ... #Endocrinology
Acute Kidney Injury (AKI) - Differential Diagnosis Framework Pre-Renal: • Hypovolemia, Cardiorenal, Distributive Shock, HRS, Hypercalcemia, Renal
Compartment Syndrome, Medications ... Pigment, Protein) • AIN ... : Medication, Infection ... , DM) SCVMC Internal ... Differential #Diagnosis #nephrology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
commonly used medications ... to treat Type 2 Diabetes ... mistaken these medications ... injection site pain ... #DM2 #Endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology Summary ... Ozempic), or daily tablet ... #Pharmacology #Summary ... #DM2 #diabetes ... #endocrinology
empty